Skip to main content
S 3496 117th Congress Senate Health Emergency medical services and trauma care Government information and archives Health technology, devices, supplies Infectious and parasitic diseases Medical research Medical tests and diagnostic methods Product development and innovation Public contracts and procurement Research administration and funding Research and development

Promoting ACCESS to Diagnostics Act

Introduced: January 13, 2022 See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jan 13, 2022
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Jan 13, 2022
Introduced in Senate
 Plain-English summary Congressional Research Service

Promoting Access to Critical Countermeasures by Ensuring Specimen Samples to Diagnostics Act or the Promoting ACCESS to Diagnostics Act

This bill directs the Department of Health and Human Services (HHS) to support the development of medical products and diagnostic tests for emerging infectious diseases.

Specifically, HHS must develop policies and procedures governing access by public and private entities to samples of pathogens (or suitable surrogates). The samples may be used for preparedness and response activities, developing medical products for emerging infectious diseases, and similar purposes.

Additionally, HHS may contract with public and private entities to increase the capacity to rapidly develop, validate, and disseminate diagnostic tests to health departments and other entities to respond to emerging infectious diseases with significant potential to cause a public health emergency.

What's happening now January 13, 2022

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Committees of jurisdiction 1
 Cosponsors 1
All 1 Democratic 1